J9119 – Injection, cemiplimab-rwlc, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9119
- Long description
- Injection, cemiplimab-rwlc, 1 mg
- Short description
- Inj., cemiplimab-rwlc, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2019
- Last change
- October 1, 2019 – No change
Frequently asked questions
What is HCPCS code J9119?
J9119 is a HCPCS Level II code for injection, cemiplimab-rwlc, 1 mg.
Does Medicare cover J9119?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9072 – Injection, cyclophosphamide (frindovyx), 5 mg
- J9073 – Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074 – Injection, cyclophosphamide (sandoz), 5 mg
- J9075 – Injection, cyclophosphamide, not otherwise specified, 5 mg
- J9076 – Injection, cyclophosphamide (baxter), 5 mg
- J9098 – Injection, cytarabine liposome, 10 mg
- J9100 – Injection, cytarabine, 100 mg
- J9118 – Injection, calaspargase pegol-mknl, 10 units
- J9120 – Injection, dactinomycin, 0.5 mg
- J9130 – Dacarbazine, 100 mg
- J9144 – Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 – Injection, daratumumab, 10 mg
- J9150 – Injection, daunorubicin, 10 mg
- J9151 – Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 – Injection, degarelix, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.